Elevated levels of macrophage migration inhibitory factor (MIF) in the plasma of HIV-1-infected patients and in HIV-1-infected cell cultures: A relevant role on viral replication

Virology

Volumn 399, Issue 1, 2010, Pages 31-38

  Regis, Eduardo G ^a   Barreto de Souza, Victor ^a   Morgado, Mariza G ^a   Bozza, Marcelo T ^b   Leng, Lin ^c   Bucala, Richard ^c   Bou Habib, Dumith C ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; gp120; HIV 1; LTR; MIF

Indexed keywords

ABC TRANSPORTER A1; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120; MACROPHAGE MIGRATION INHIBITION FACTOR; PROBENECID;

ARTICLE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL LINEAGE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LONG TERMINAL REPEAT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; VIRUS ACTIVATION; VIRUS ISOLATION; VIRUS LOAD; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; LEUKOCYTES, MONONUCLEAR; MACROPHAGE MIGRATION-INHIBITORY FACTORS; PROBENECID; RECOMBINANT PROTEINS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77049100935     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.12.018     Document Type: Article

References (64)

1. Aguilar-Cordova E., Chinen J., Donehower L., Lewis D.E., and Belmont J.W. A sensitive reporter cell line for HIV-1 tat activity, HIV-1 inhibitors, and T cell activation effects. AIDS Res. Hum. Retroviruses 10 3 (1994) 295-301
2. Alfano M., Crotti A., Vicenzi E., and Poli G. New players in cytokine control of HIV infection. Curr. HIV/AIDS Rep. 5 1 (2008) 27-32
3. Amano T., Nishihira J., and Miki I. Blockade of macrophage migration inhibitory factor (MIF) prevents the antigen-induced response in a murine model of allergic airway inflammation. Inflamm. Res. 56 1 (2007) 24-31
4. Amin M.A., Haas C.S., Zhu K., Mansfield P.J., Kim M.J., Lackowski N.P., and Koch A.E. Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NFkappaB. Blood 107 6 (2006) 2252-2261
5. Arjona A., Foellmer H.G., Town T., Leng L., McDonald C., Wang T., Wong S.J., Montgomery R.R., Fikrig E., and Bucala R. Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion. J. Clin. Invest. 117 10 (2007) 3059-3066
6. Arndt U., Wennemuth G., Barth P., Nain M., Al-Abed Y., Meinhardt A., Gemsa D., and Bacher M. Release of macrophage migration inhibitory factor and CXCL8/interleukin-8 from lung epithelial cells rendered necrotic by influenza A virus infection. J. Virol. 76 18 (2002) 9298-9306
7. Awandare G.A., Kremsner P.G., Hittner J.B., Keller C.C., Clark I.A., Weinberg J.B., and Perkins D.J. Higher production of peripheral blood macrophage migration inhibitory factor in healthy children with a history of mild malaria relative to children with a history of severe malaria. Am. J. Trop. Med. Hyg. 76 6 (2007) 1033-1036
8. Ayoub S., Hickey M.J., and Morand E.F. Mechanisms of disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis. Nat. Clin. Pract. Rheumatol. 4 2 (2008) 98-105
9. Bacher M., Eickmann M., Schrader J., Gemsa D., and Heiske A. Human cytomegalovirus-mediated induction of MIF in fibroblasts. Virology 299 1 (2002) 32-37
10. Baugh J.A., and Bucala R. Macrophage migration inhibitory factor. Crit. Care Med. 30 1 Supp (2002) S27-S35
11. Bernhagen J., Krohn R., Lue H., Gregory J.L., Zernecke A., Koenen R.R., Dewor M., Georgiev I., Schober A., Leng L., Kooistra T., Fingerle-Rowson G., Ghezzi P., Kleemann R., McColl S.R., Bucala R., Hickey M.J., and Weber C. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 13 5 (2007) 587-596
12. Bernhagen J., Mitchell R.A., Calandra T., Voelter W., Cerami A., and Bucala R. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 33 47 (1994) 14144-14155
13. Binsky I., Haran M., Starlets D., Gore Y., Lantner F., Harpaz N., Leng L., Goldenberg D.M., Shvidel L., Berrebi A., Bucala R., and Shachar I. IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival. Proc. Natl. Acad. Sci. U.S.A. 104 33 (2007) 13408-13413
14. Bozza F.A., Gomes R.N., Japiassu A.M., Soares M., Castro-Faria-Neto H.C., Bozza P.T., and Bozza M.T. Macrophage migration inhibitory factor levels correlate with fatal outcome in sepsis. Shock 22 4 (2004) 309-313
15. Bozza M., Satoskar A.R., Lin G., Lu B., Humbles A.A., Gerard C., and David J.R. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J. Exp. Med. 189 2 (1999) 341-346
16. Brenchley J.M., Price D.A., and Douek D.C. HIV disease: fallout from a mucosal catastrophe. Nat. Immunol. 7 3 (2006) 235-239
17. Brenchley J.M., Price D.A., Schacker T.W., Asher T.E., Silvestri G., Rao S., Kazzaz Z., Bornstein E., Lambotte O., Altmann D., Blazar B.R., Rodriguez B., Teixeira-Johnson L., Landay A., Martin J.N., Hecht F.M., Picker L.J., Lederman M.M., Deeks S.G., and Douek D.C. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12 12 (2006) 1365-1371
18. Calandra T., Bernhagen J., Mitchell R.A., and Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med. 179 6 (1994) 1895-1902
19. Calandra T., Echtenacher B., Roy D.L., Pugin J., Metz C.N., Hultner L., Heumann D., Mannel D., Bucala R., and Glauser M.P. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat. Med. 6 2 (2000) 164-170
20. Calandra T., and Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 3 10 (2003) 791-800
21. Capobianchi M.R. Induction of lymphomonocyte activation by HIV-1 glycoprotein gp120. Possible role in AIDS pathogenesis. J. Biol. Regul. Homeost. Agents 10 4 (1996) 83-91
22. Chen L.C., Lei H.Y., Liu C.C., Shiesh S.C., Chen S.H., Liu H.S., Lin Y.S., Wang S.T., Shyu H.W., and Yeh T.M. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am. J. Trop. Med. Hyg. 74 1 (2006) 142-147
23. Chiodi F., Bredberg-Raden U., Biberfeld G., Bottiger B., Albert J., Asjo B., Fenyo E.M., and Norrby E. Radioimmunoprecipitation and Western blotting with sera of human immunodeficiency virus infected patients: a comparative study. AIDS Res. Hum. Retroviruses 3 2 (1987) 165-176
24. Connor R.I., Sheridan K.E., Ceradini D., Choe S., and Landau N.R. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 185 4 (1997) 621-628
25. Copeland K.F. Modulation of HIV-1 transcription by cytokines and chemokines. Mini Rev. Med. Chem. 5 12 (2005) 1093-1101
26. Dalgleish A.G., Beverley P.C., Clapham P.R., Crawford D.H., Greaves M.F., and Weiss R.A. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312 5996 (1984) 763-767
27. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R.E., Hill C.M., Davis C.B., Peiper S.C., Schall T.J., Littman D.R., and Landau N.R. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381 6584 (1996) 661-666
28. Donnelly S.C., Haslett C., Reid P.T., Grant I.S., Wallace W.A., Metz C.N., Bruce L.J., and Bucala R. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat. Med. 3 3 (1997) 320-323
29. Duh E.J., Maury W.J., Folks T.M., Fauci A.S., and Rabson A.B. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc. Natl. Acad. Sci. U.S.A. 86 15 (1989) 5974-5978
30. Emonts M., Sweep F.C., Grebenchtchikov N., Geurts-Moespot A., Knaup M., Chanson A.L., Erard V., Renner P., Hermans P.W., Hazelzet J.A., and Calandra T. Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis. Clin. Infect. Dis. 44 10 (2007) 1321-1328
31. Feng Y., Broder C.C., Kennedy P.E., and Berger E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272 5263 (1996) 872-877
32. Finnegan A., Roebuck K.A., Nakai B.E., Gu D.S., Rabbi M.F., Song S., and Landay A.L. IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage. J. Immunol. 156 2 (1996) 841-851
33. Flieger O., Engling A., Bucala R., Lue H., Nickel W., and Bernhagen J. Regulated secretion of macrophage migration inhibitory factor is mediated by a non-classical pathway involving an ABC transporter. FEBS Lett. 551 1-3 (2003) 78-86
34. Gando S., Sawamura A., Hayakawa M., Hoshino H., Kubota N., and Nishihira J. High macrophage migration inhibitory factor levels in disseminated intravascular coagulation patients with systemic inflammation. Inflammation 30 3-4 (2007) 118-124
35. Gore Y., Starlets D., Maharshak N., Becker-Herman S., Kaneyuki U., Leng L., Bucala R., and Shachar I. Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex. J. Biol. Chem. 283 5 (2008) 2784-2792
36. He X.X., Yang J., Ding Y.W., Liu W., Shen Q.Y., and Xia H.H. Increased epithelial and serum expression of macrophage migration inhibitory factor (MIF) in gastric cancer: potential role of MIF in gastric carcinogenesis. Gut 55 6 (2006) 797-802
37. Hladik F., and McElrath M.J. Setting the stage: host invasion by HIV. Nat. Rev. Immunol. 8 6 (2008) 447-457
38. Hoi A.Y., Iskander M.N., and Morand E.F. Macrophage migration inhibitory factor: a therapeutic target across inflammatory diseases. Inflamm. Allergy Drug Targets 6 3 (2007) 183-190
39. Ichiyama H., Onodera S., Nishihira J., Ishibashi T., Nakayama T., Minami A., Yasuda K., and Tohyama H. Inhibition of joint inflammation and destruction induced by anti-type II collagen antibody/lipopolysaccharide (LPS)-induced arthritis in mice due to deletion of macrophage migration inhibitory factor (MIF). Cytokine 26 5 (2004) 187-194
40. Javeed A., and Zhao Y. Macrophage-migration inhibitory factor: role in inflammatory diseases and graft rejection. Inflamm. Res. 57 2 (2008) 45-50
41. Kedzierska K., and Crowe S.M. Cytokines and HIV-1: interactions and clinical implications. Antivir. Chem. Chemother. 12 3 (2001) 133-150
42. Kinter A., Arthos J., Cicala C., and Fauci A.S. Chemokines, cytokines and HIV: a complex network of interactions that influence HIV pathogenesis. Immunol. Rev. 177 (2000) 88-98
43. Klasse P.J., and Moore J.P. Is there enough gp120 in the body fluids of HIV-1-infected individuals to have biologically significant effects. Virology 323 1 (2004) 1-8
44. Kleemann R., Hausser A., Geiger G., Mischke R., Burger-Kentischer A., Flieger O., Johannes F.J., Roger T., Calandra T., Kapurniotu A., Grell M., Finkelmeier D., Brunner H., and Bernhagen J. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408 6809 (2000) 211-216
45. Larson D.F., and Horak K. Macrophage migration inhibitory factor: controller of systemic inflammation. Crit. Care 10 2 (2006) 138
46. Lee P.I., Ciccone E.J., Read S.W., Asher A., Pitts R., Douek D.C., Brenchley J.M., and Sereti I. Evidence for translocation of microbial products in patients with idiopathic CD4 lymphocytopenia. J. Infect. Dis. 199 11 (2009) 1664-1670
47. Leng L., Metz C.N., Fang Y., Xu J., Donnelly S., Baugh J., Delohery T., Chen Y., Mitchell R.A., and Bucala R. MIF signal transduction initiated by binding to CD74. J. Exp. Med. 197 11 (2003) 1467-1476
48. Lima R.G., Van Weyenbergh J., Saraiva E.M., Barral-Netto M., Galvao-Castro B., and Bou-Habib D.C. The replication of human immunodeficiency virus type 1 in macrophages is enhanced after phagocytosis of apoptotic cells. J. Infect. Dis. 185 11 (2002) 1561-1566
49. Meazza C., Travaglino P., Pignatti P., Magni-Manzoni S., Ravelli A., Martini A., and De Benedetti F. Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis. Arthritis Rheum. 46 1 (2002) 232-237
50. Mitchell R.A., Liao H., Chesney J., Fingerle-Rowson G., Baugh J., David J., and Bucala R. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc. Natl. Acad. Sci. U.S.A. 99 1 (2002) 345-350
51. Munoz-Fernandez M.A., Navarro J., Garcia A., Punzon C., Fernandez-Cruz E., and Fresno M. Replication of human immunodeficiency virus-1 in primary human T cells is dependent on the autocrine secretion of tumor necrosis factor through the control of nuclear factor-kappa B activation. J. Allergy Clin. Immunol. 100 6 Pt 1 (1997) 838-845
52. Neil S.J., Zang T., and Bieniasz P.D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451 7177 (2008) 425-430
53. Orenstein J.M., Fox C., and Wahl S.M. Macrophages as a source of HIV during opportunistic infections. Science 276 5320 (1997) 1857-1861
54. Ortigao-de-Sampaio M.B., Shattock R.J., Hayes P., Griffin G.E., Linhares-de-Carvalho M.I., Ponce de Leon A., Lewis D.J., and Castello-Branco L.R. Increase in plasma viral load after oral cholera immunization of HIV-infected subjects. AIDS 12 14 (1998) F145-F150
55. Schols D., and De Clercq E. Human immunodeficiency virus type 1 gp120 induces anergy in human peripheral blood lymphocytes by inducing interleukin-10 production. J. Virol. 70 8 (1996) 4953-4960
56. Shi X., Leng L., Wang T., Wang W., Du X., Li J., McDonald C., Chen Z., Murphy J.W., Lolis E., Noble P., Knudson W., and Bucala R. CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 25 4 (2006) 595-606
57. Stanley S.K., Ostrowski M.A., Justement J.S., Gantt K., Hedayati S., Mannix M., Roche K., Schwartzentruber D.J., Fox C.H., and Fauci A.S. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N. Engl. J. Med. 334 19 (1996) 1222-1230
58. Stevenson M. HIV-1 pathogenesis. Nat. Med. 9 7 (2003) 853-860
59. Stopak K.S., Chiu Y.L., Kropp J., Grant R.M., and Greene W.C. Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells. J. Biol. Chem. 282 6 (2007) 3539-3546
60. Toh M.L., Aeberli D., Lacey D., Yang Y., Santos L.L., Clarkson M., Sharma L., Clyne C., and Morand E.F. Regulation of IL-1 and TNF receptor expression and function by endogenous macrophage migration inhibitory factor. J. Immunol. 177 7 (2006) 4818-4825
61. Toossi Z., Sierra-Madero J.G., Blinkhorn R.A., Mettler M.A., and Rich E.A. Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus type 1. J. Exp. Med. 177 5 (1993) 1511-1516
62. Varthakavi V., Heimann-Nichols E., Smith R.M., Sun Y., Bram R.J., Ali S., Rose J., Ding L., and Spearman P. Identification of calcium-modulating cyclophilin ligand as a human host restriction to HIV-1 release overcome by Vpu. Nat. Med. 14 6 (2008) 641-647
63. Wahl S.M., Greenwell-Wild T., Peng G., Hale-Donze H., and Orenstein J.M. Co-infection with opportunistic pathogens promotes human immunodeficiency virus type 1 infection in macrophages. J. Infect. Dis. 179 Suppl 3 (1999) S457-S460
64. Zhang Y.J., Fadeel B., Hodara V., and Fenyo E.M. Induction of apoptosis by primary HIV-1 isolates correlates with productive infection in peripheral blood mononuclear cells. AIDS 11 10 (1997) 1219-1225